Paid Clinical Trials Alabama
Discover 1,038 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Acceptance and Commitment Therapy for Depressed People With Spinal Cord InjuriesAcceptance and Commitment Therapy for Depressed People With Spinal Cord Injuries
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06233656
Conditions
Depression
Spinal Cord Injuries
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Acceptance and commitment therapy (ACT)
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
Sponsor:
University of North Carolina, Chapel Hill
Location:
Code:
NCT03554356
Conditions
Barrett Esophagus
Intestinal Metaplasia
Esophageal Dysplasia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CryoBalloon Focal Ablation System
A Community Health Worker Intervention to Address Adverse Pregnancy OutcomesA Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06353256
Conditions
Preeclampsia Postpartum
Adverse Pregnancy Outcomes
Eligibility Criteria
Sex: Female
Age: 16 - 56
Healthy Volunteers: Accepted
Interventions
usual postpartum care
usual postpartum care + community health worker intervention
MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Location:
Code:
NCT06431256
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 4 - 5
Healthy Volunteers: Not accepted
Interventions
HLD200 methylphenidate hydrochloride capsules
Placebo HLD200 capsules
Standard Care & BR-ACNon-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Sponsor:
BioStem Technologies
Location:
Code:
NCT06811909
Conditions
Non-infected Venous Leg Ulcer
Venous Leg Ulcer
Venous Insufficiency
Venous Stasis
Venous Reflux
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BR-AC
Standard Care
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
RESTORERESTORE: REducing Future FractureS and Improving OuTcOmes of FRagility FracturE
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06455085
Conditions
Osteoporosis
Osteoporotic Fractures
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Augmented-Fracture Liaison Service Arm
Enhanced Usual Care Arm
BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Sponsor:
Blueprint Medicines Corporation
Location:
Code:
NCT04910685
Conditions
Indolent Systemic Mastocytosis
Monoclonal Mast Cell Activation Syndrome
Smoldering Systemic Mastocytosis
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
Elenestinib
Placebo
Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry
Sponsor:
Parkinson's Foundation
Location:
Code:
NCT04994015
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lab Assay for seven genetic variants for Parkinson's Disease
Prenatal InterventionPrenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT04615715
Conditions
Maternal Cytomegalovirus Infections
Cytomegalovirus Congenital
Eligibility Criteria
Sex: Female
Age: 14 - 39
Healthy Volunteers: Accepted
Interventions
CMV Risk-Reduction Intervention
Stress Reduction Messaging